Curocell (XKRX:372320) ROCE % : -103.09% (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Curocell ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Curocell's annualized ROCE % for the quarter that ended in Dec. 2024 was -103.09%.

Curocell ROCE % Historical Data

The historical data trend for Curocell's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell ROCE % Chart

Curocell Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-3,710.48

-65.59

-52.80

Curocell Quarterly Data
	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial					-28.93	-43.04	-51.45	-81.11	-103.09

Curocell ROCE % Calculation

Curocell's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-35634.952	/	( ( (104969.386 - 3270.412)	+	(72021.277 - 38751.336) )	/ 2 )
	=	-35634.952	/	( (101698.974	+	33269.941)	/ 2 )
	=	-35634.952	/	67484.4575
	=	-52.80 %

Curocell's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-39670.512	/	( ( (80644.799 - 36954.998)	+	(72021.277 - 38751.336) )	/ 2 )
	=	-39670.512	/	( ( 43689.801	+	33269.941 )	/ 2 )
	=	-39670.512	/	38479.871
	=	-103.09 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Curocell (XKRX:372320) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Curocell ROCE % Related Terms

Thank you for viewing the detailed overview of Curocell's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002

Website

https://www.curocellbtx.com

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell Headlines

No Headlines